Targacept Inc (TRGT.OQ)

TRGT.OQ on NASDAQ Stock Exchange Global Select Market

5.04USD
10:49am EDT
Price Change (% chg)

$0.04 (+0.80%)
Prev Close
$5.00
Open
$5.00
Day's High
$5.04
Day's Low
$4.96
Volume
5,306
Avg. Vol
59,397
52-wk High
$5.77
52-wk Low
$3.86

TRGT.OQ

Chart for TRGT.OQ

About

Targacept, Inc. is a biopharmaceutical company. The Company is engaged in the design, discovery and development of NNR Therapeutics for the treatment of diseases and disorders of the nervous system. The Company's NNR Therapeutics target neuronal nicotinic receptors (NNRs). As of December 31, 2011, the Company had multiple... (more)

Overall

Beta: 3.16
Market Cap (Mil.): $168.09
Shares Outstanding (Mil.): 33.62
Dividend: --
Yield (%): --

Financials

  TRGT.OQ Industry Sector
P/E (TTM): -- 37.93 37.76
EPS (TTM): -0.52 -- --
ROI: -9.81 19.48 18.76
ROE: -9.95 20.17 19.59
Search Stocks

Competitors

  Price Change
Eisai Co., Ltd (4523.T) ¥4,165 +20.00
Pfizer Inc. (PFE.N) $29.18 -0.05
Johnson & Johnson (JNJ.N) $93.90 +0.40
Novartis AG (NOVN.VX) CHF66.60 +0.35
Merck & Co., Inc. (MRK.N) $48.13 -0.04
Roche Holding Ltd. (ROG.VX) CHF228.00 -3.50
Abbott Laboratories (ABT.N) $36.91 +0.28
Sanofi SA (SASY.PA) €76.26 -3.91
AstraZeneca plc (AZN.L) 3,311.50p -23.50
GlaxoSmithKline plc (GSK.L) 1,706.50p +22.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks